J&J报告说,新的psoralpic药物取得了有希望的成果,有可能提供口服治疗选择。 J&J reports promising results for new psoriasis drug, potentially offering oral treatment option.

Johnson & Johnson报告说,关于他们新口服的松丝虫病药物的后期研究取得了积极成果,表明白斑松丝虫病患者的皮肤清理工作有了显著改善。 Johnson & Johnson has reported positive results from a late-stage study of their new oral drug for psoriasis, showing significant improvements in skin clearance for patients with plaque psoriasis. 毒品是J&J和Protragonist之间的一种合作。 The drug is a collaboration between J&J and Protagonist. 如果获得批准,它可以为皮肤病患者提供一种新的治疗选择。 If approved, it could offer a new treatment option for those suffering from the skin condition.